Concepedia

Impact of rivaroxaban on point-of-care assays

Pierre Fontana, Lorenzo Alberio, Anne Angelillo‐Scherrer, Lars M. Asmis, Wolfgang Korte, Adriana Méndez, P. Schmid, Hans Stricker, Jan–Dirk Studt, Dimitrios A. Tsakiris,

Thrombosis Research · 2017 · 37 citations · 28 references

DOI

Concepts

References

28

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · New England Journal of Medicine · 2016 · 1.6K citations · Full text

, , +17

Multi-centre investigation on reference ranges for ROTEM thromboelastometry

Thomas Lang�, Anne Bauters, Siegmund Braun et al. · Blood Coagulation & Fibrinolysis · 2005 · 501 citations

, , +16

Determination of rivaroxaban – a novel, oral, direct Factor Xa inhibitor – in human plasma by high-performance liquid chromatography–tandem mass spectrometry

G. Rohde · Journal of Chromatography B · 2008 · 140 citations

, , +10

Use of Thromboelastography (TEG) for Detection of New Oral Anticoagulants

João D. Dias, Katherine Norem, Derek D. Doorneweerd et al. · Archives of Pathology & Laboratory Medicine · 2015 · 138 citations

, , +17

Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests

Thomas Eller, Jessica Busse, Marcus Dittrich et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2014 · 111 citations

, , +17